Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.88x is 72% above its 5-year average of 1.09x, around the middle of its 5-year range (-0.62x–3.92x).
32.07% below its 12-month average of 2.77x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 3.92x.
INTEREST COVERAGE RATIO
1.88x
INTEREST COVERAGE RATIO AVG TTM
2.77x
INTEREST COVERAGE RATIO AVG 3Y
1.49x
INTEREST COVERAGE RATIO AVG 5Y
1.09x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.07%
CURRENT VS 3Y AVG
+26.53%
CURRENT VS 5Y AVG
+71.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-1.90x
median of 252 covered companies
CURRENT VS SECTOR MEDIAN
+198.69%
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Interest Coverage Ratio
1.88x
TTM Avg
2.77x
3Y Avg
1.49x
5Y Avg
1.09x
Market Cap
$12.00B
Interest Coverage Ratio
8.55x
TTM Avg
7.42x
3Y Avg
7.61x
5Y Avg
6.89x
Market Cap
$12.49B
Interest Coverage Ratio
144.35x
TTM Avg
102.58x
3Y Avg
62.73x
5Y Avg
62.73x
Market Cap
$12.52B
Interest Coverage Ratio
-1.06x
TTM Avg
0.71x
3Y Avg
2.65x
5Y Avg
6.89x
Market Cap
$11.47B
Interest Coverage Ratio
3.66x
TTM Avg
4.05x
3Y Avg
3.97x
5Y Avg
4.62x
Market Cap
$12.89B
Interest Coverage Ratio
5.38x
TTM Avg
5.00x
3Y Avg
4.08x
5Y Avg
8.08x
Market Cap
$12.95B
Interest Coverage Ratio
-10.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.36B
Interest Coverage Ratio
46.60x
TTM Avg
29.31x
3Y Avg
24.60x
5Y Avg
23.61x
Market Cap
$13.19B
Interest Coverage Ratio
N/A
TTM Avg
541.83x
3Y Avg
541.83x
5Y Avg
541.83x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 1.88x | 2.77x | 1.49x | 1.09x |
| Encompass Health Corporation (EHC)vs › | $12.00B | 8.55x | 7.42x | 7.61x | 6.89x |
| Penumbra, Inc. (PEN)vs › | $12.49B | 144.35x | 102.58x | 62.73x | 62.73x |
| Baxter International Inc. (BAX)vs › | $12.52B | -1.06x | 0.71x | 2.65x | 6.89x |
| DaVita Inc. (DVA)vs › | $11.47B | 3.66x | 4.05x | 3.97x | 4.62x |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 5.38x | 5.00x | 4.08x | 8.08x |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -10.72x | N/A | N/A | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 46.60x | 29.31x | 24.60x | 23.61x |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | N/A | 541.83x | 541.83x | 541.83x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 48.95x | 43.59x | 27.00x | 27.00x |
Interest Coverage
1.9x
Debt/Equity
1.17
Current Ratio
1.59
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 3.92x |
| 2026-03-31 | 3.56x |
| 2025-12-31 | 2.81x |
| 2025-09-30 | 2.30x |
| 2025-06-30 | 1.25x |
| 2025-03-31 | 1.21x |
| 2024-12-31 | 1.44x |
| 2024-09-30 | 1.01x |
| 2024-06-30 | 0.89x |
| 2024-03-31 | -0.28x |
| 2023-12-31 | 0.82x |
| 2023-09-30 | -0.62x |
| 2023-06-30 | 1.00x |
| 2023-03-31 | 0.66x |
| 2022-12-31 | 0.31x |
| 2022-09-30 | 0.57x |
| 2022-06-30 | 1.36x |
| 2022-03-31 | 1.36x |
| 2021-12-31 | 1.45x |
| 2021-09-30 | 1.57x |
| 2021-06-30 | 1.68x |
| 2021-03-31 | 1.51x |
| 2020-12-31 | 1.35x |
| 2020-09-30 | 1.72x |
| 2020-06-30 | 1.15x |
| 2020-03-31 | 0.97x |
| 2019-12-31 | 1.05x |
| 2019-09-30 | 0.95x |
| 2019-06-30 | 0.80x |
